Raymond James analyst compares cannabis company Cronos Group Inc. (TSX:CRON) to Apple Inc.’s (NASDAQ:AAPL) development in the 1970s
SmallCapPower | May 20, 2020: In what seems like a crazy comparison, Raymond James analyst Rahul Sarugaser likens cannabis company Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) to Apple Inc.’s (NASDAQ:AAPL) development in the 1970s.
In a research note to clients following the release of Cronos’ Q1 financial results on May 8, Mr. Sarugaser expects the cannabis grower/distributor will dominate the marijuana market with its technology and intellectual property. He cited Cronos’ partnership with Ginkgo Bioworks, which has successfully engineered its first set of organisms to produce cannabinoids by biosynthesis.
“This is a big development. We recommend investors take note,” arguing that this biosynthesis technology will “propel Cronos to the forefront of the cannabinoid consumer product space not in five years, but maybe two.”
“Anyone interested in buying pre-IPO AAPL shares?” the Raymond James analyst wrote.
While Apple Inc is well known for its large cash holding, Cronos Group also has a notable amount of money on the books, ending the first-quarter 2020 with cash and equivalents of US$1.128 billion.
Shares of Cronos Group are down 11% during the past month, to its current price of C$7.67, and the stock is off 23% year to date.
Cannabis stocks have received some investor love during the past week after Aurora Cannabis Inc. (TSX:ACB) announced a pathway to profitability during the next year. Shares of Aurora have soared 146% during the past three trading sessions on TSX as of Tuesday’s close.
Canaccord Genuity, meanwhile, cuts its target price on Aurora Cannabis stock from C$27.00 to C$24.00 on Tuesday.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
 (NASDAQ:CRON) to Apple Inc.’s (NASDAQ:AAPL) development in the 1970s.){kind=link}